Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine
Nephrology
Dr. Domenic A. Sica, MD
|
|
Give Review
Domenic Sica works in the field of Nephrology. He researched medicine at Virginia Commonwealth University School of Medicine. He over the years received 1 awards: "Regional Top Doctor". Domenic A. Sica has written publications. He has 100 publications published with PubMed. The lastest paper is: 'Bilateral or Unilateral Stimulation for Baroreflex Activation Therapy.' He is registered with Medicare and accepts Medicare payments.
Publications
- Bilateral or Unilateral Stimulation for Baroreflex Activation Therapy.
- Urinary potassium excretion: can it predict the onset of Hypertension?
- Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results.
- Aldosterone and Volume Management in Hypertensive Heart Disease.
- Proceedings from the society of interventional radiology foundation research consensus panel on Renal sympathetic denervation.
- More Salt is Better: A Novel Management Approach to Acute Decompensated Heart Failure.
- Effects of combining azilsartan medoxomil With amlodipine in patients With stage 2 hypertension.
- Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined With azilsartan medoxomil.
- Renal Sympathetic Denervation for the Treatment of Systemic Hypertension.
- Azilsartan Medoxomil Plus Chlorthalidone Reduces Blood Pressure More Effectively Than Olmesartan Plus Hydrochlorothiazide in Stage 2 Systolic Hypertension.
- Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study.
- Impact of low-dose B-type natriuretic peptide infusion on urine output after total artificial Heart implantation.
- Nondrug interventions for the treatment of Hypertension: varying effect.
- Diuretic use in renal Disease.
- Acetazolamide: a forgotten diuretic agent.
- Curcumin and enalapril ameliorates renal Failure by antagonizing inflammation in 5/6 nephrectomized rats: Role of phospholipase and cyclooxygenase.
- What is the Role of Aldosterone Excess in Resistant Hypertension and How Should It Be Investigated and Treated?
- Therapeutic perspectives in Hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.
- Drug dosing consideration in patients with Acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
- Thiazide and loop diuretics.
- Baroreflex activation therapy lowers blood pressure in patients With resistant hypertension results from the double-blind, randomized, placebo-controlled rheos pivotal...
- Chlorthalidone versus hydrochlorothiazide as the preferred diuretic: is there a verdict yet?
- Rheos: an implantable carotid sinus stimulation device for the nonpharmacologic treatment of resistant Hypertension.
- Device-guided breathing and Hypertension: a yet to be determined positioning.
- On the waterfront.
- Treatment considerations With aldosterone receptor antagonists.
- Beyond conventional considerations: newer devices used in blood pressure measurement and management.
- Pharmacologic Issues in treating Hypertension in CKD.
- Curcumin prevents cardiac remodeling secondary to chronic renal Failure through deactivation of hypertrophic signaling in rats.
- Drug combinations in the treatment of Hypertension: never-ending novelty.
- The evolution of renin-angiotensin blockade: angiotensin-converting enzyme inhibitors as the starting point.
- Can focused US With a diagnostic US contrast agent favorably affect renal function?
- Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart Failure progression in a canine high-rate pacing model.
- The editor's roundtable: preHypertension.
- Fibrate therapy and Renal function.
- Pamidronate-induced Kidney injury in a patient with metastatic breast cancer.
- Hyperkalemia risk in chronic Kidney disease: deterrent to the use of aldosterone receptor antagonism or not.
- Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients With the cardiometabolic synd...
- Direct renin inhibition--commonly asked questions.
- Do pleiotropic effects of antiHypertensive medications exist or is it all about the blood pressure?
- Edema mechanisms in the patient with heart Failure and treatment options.
- Endothelin receptor antagonism: what does the future hold?
- Management of Hypertension in the outpatient setting.
- Pharmacologic considerations in the positioning of beta-blockers in antiHypertensive therapy.
- The Kidney and hypertension: causes and treatment.
- Endocrine causes of secondary Hypertension.
- Hypertension control: still not there-how to select the right add-on therapy to reach goal blood pressures.
- Use of diuretics in the treatment of heart Failure in the elderly.
- Acute phosphate nephropathy following colonoscopy preparation.
- Acute phosphate nephropathy--an emerging issue.
- AntiHypertensive medications and anemia.
- Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.
- The use of renin inhibitors in the management of Hypertension.
- Hypertension treatment: how important is consistency of effect?
- Obstructive sleep apnea, Hypertension, and wakefulness-promoting agents.
- Spironolactone use in resistant Hypertension.
- Loop diuretic therapy, thiamine balance, and heart Failure.
- Centrally acting antiHypertensive agents: an update.
- Angiotensin-converting enzyme inhibitor-related angioedema: recognition and treatment.
- Combination ACE inhibitor and angiotensin receptor blocker therapy - future considerations.
- Taking the pressure off type 2 Diabetes mellitus: implementing hypertension guidelines.
- Efficacy of a once-daily formulation of carvedilol for the treatment of Hypertension.
- Controlled-release carvedilol in the treatment of essential Hypertension.
- Design of a novel controlled-release formulation of carvedilol: pharmacology and clinical aspects. Introduction.
- The Valsartan AntiHypertensive Long-Term Use Evaluation trial: a study in contrasts.
- Drospirenone: an antiHypertensive in waiting.
- Angiotensin-receptor blockers for preHypertension.
- Interaction of grapefruit juice and calcium channel blockers.
- Angiotensin-converting enzyme inhibition-emerging pulmonary issues relating to cough.
- Spironolactone: an old friend rediscovered.
- Sodium and water retention in heart Failure and diuretic therapy: basic mechanisms.
- Angiotensin receptor blockers: new considerations in their mechanism of action.
- Angiogenesis inhibitors and Hypertension: an emerging issue.
- Chlorthalidone: has it always been the best thiazide-type diuretic?
- BiDil (isosorbide dinitrate and hydralazine hydrochloride).
- AntiHypertensive therapy and its effects on potassium homeostasis.
- Hyponatremia and heart Failure--treatment considerations.
- Pharmacotherapy review: calcium channel blockers.
- Alpha1-adrenergic blockers: current usage considerations.
- Pharmacotherapy review: Angiotensin receptor antagonists.
- ACE inhibitors: over two decades of use.
- Hyponatremia and heart Failure--pathophysiology and implications.
- Transdermal clonidine: therapeutic considerations.
- Angiotensin-converting enzyme inhibitor use in the year 2005.
- Clinical trials report. White-coat Hypertension and stroke incidence.
- Pharmacotherapy review: angiotensin-converting enzyme inhibitors.
- The risks and benefits of aldosterone antagonists.
- Pharmacokinetics of eplerenone after single and multiple dosing in subjects With and Without renal impairment.
- Stroke in patients with Diabetes and hypertension.
- Gender and its effect in cardiovascular pharmacotherapeutics: recent considerations.
- Over-the-counter statin therapy--pros and cons.
- Comparison of blood pressure control With amlodipine and controlled-release isradipine: an open-label, drug substitution study.
- Calcium channel blocker class heterogeneity: select aspects of pharmacokinetics and pharmacodynamics.
- Therapeutic considerations in the African-American patient With hypertension: considerations With calcium channel blocker therapy.
- Calcium channel blockers: a more expansive treatment role.
- New considerations relating to class effect With angiotensin-converting enzyme inhibitors--the PEACE study.
- Diuretics should continue to be one of the preferred initial therapies in the management of Hypertension: the argument against.
- Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient With hypertension.
- Pharmacokinetics and pharmacodynamics of Mineralocorticoid blocking agents and their effects on potassium homeostasis.
Schools
Virginia Commonwealth University School Of Medicine
Mc Va Hospital
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acute Kidney Failure
- Chronic Kidney Diseases
- Congenital Cystic Kidney Disease
- Congenital Polycystic Kidney Disease
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Texas Health Science Center -
Virginia Commonwealth University Health System -
Virginia Commonwealth University School of Medicine
Drug Facts
| NPI NUMBER | 1932282811 | |
| NPPES Provider LastName | SICA | |
| NPPES Provider FirstName | DOMENIC | |
| NPPES Provider ZIPCode | 232985051 | |
| NPPES Provider State | VA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 3929.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 46.0 | |
| Percent Opioid Claims | 1.17 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932282811 |
| Last Name Of The Provider | SICA |
| First Name Of The Provider | DOMENIC |
| View All |
Similar Doctors
|
|
Dr. Walid G. Abou Assi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna K. Vinnikova, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Russell C. Ellenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Srikanth Kunaparaju, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald E. Keightley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Gayle, MD |
|
|
Dr. Chudamani K. Rao, MD |
|
|
Dr. Vicki A. Kinsel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nilang G. Patel, MD |
|
|
Dr. Deep V. Patel, MD |
|
|
Tanu Duggal, MB BS |